These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 7977900)

  • 1. Discontinuing obsessive-compulsive disorder medication with behavior therapy.
    Baer L; Ricciardi J; Keuthen N; Pettit AR; Buttolph ML; Otto M; Minichiello W; Jenike MA
    Am J Psychiatry; 1994 Dec; 151(12):1842. PubMed ID: 7977900
    [No Abstract]   [Full Text] [Related]  

  • 2. Clomipramine, fluoxetine, and behavior therapy in the treatment of obsessive-compulsive disorder: a meta-analysis.
    Cox BJ; Swinson RP; Morrison B; Lee PS
    J Behav Ther Exp Psychiatry; 1993 Jun; 24(2):149-53. PubMed ID: 8263222
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Obsessive compulsive disorder.
    J Clin Psychiatry; 1989 Jun; 50(6):231-2. PubMed ID: 2498297
    [No Abstract]   [Full Text] [Related]  

  • 4. Treatment of adolescent obsessive-compulsive disorder with a clomipramine-fluoxetine combination.
    Simeon JG; Thatte S; Wiggins D
    Psychopharmacol Bull; 1990; 26(3):285-90. PubMed ID: 2274627
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The benefits of clomipramine-fluoxetine combination in obsessive compulsive disorder.
    Browne M; Horn E; Jones TT
    Can J Psychiatry; 1993 May; 38(4):242-3. PubMed ID: 8518974
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cognitive behavioral therapy versus psychosurgery for refractory obsessive-compulsive disorder.
    Anderson SW; Booker MB
    J Neuropsychiatry Clin Neurosci; 2006; 18(1):129. PubMed ID: 16525082
    [No Abstract]   [Full Text] [Related]  

  • 7. Case study: successful medication withdrawal using cognitive-behavioral therapy for a preadolescent with OCD.
    Sallinen BJ; Nangle DW; O'Grady AC
    J Am Acad Child Adolesc Psychiatry; 2004 Nov; 43(11):1441-4. PubMed ID: 15502604
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In-patient treatment for resistant obsessive-compulsive disorder.
    Al-Sughayir MA
    Saudi Med J; 2000 Feb; 21(2):193-5. PubMed ID: 11533781
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Controlled comparisons of clomipramine and fluoxetine in the treatment of obsessive-compulsive disorder. Behavioral and biological results.
    Pigott TA; Pato MT; Bernstein SE; Grover GN; Hill JL; Tolliver TJ; Murphy DL
    Arch Gen Psychiatry; 1990 Oct; 47(10):926-32. PubMed ID: 2222131
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Drug treatment of obsessive-compulsive disorders--a comparative study of the effectiveness of clomipramine and fluoxetine].
    Volk S
    Fortschr Neurol Psychiatr; 1995 Jun; 63 Suppl 1():28-32. PubMed ID: 7635392
    [No Abstract]   [Full Text] [Related]  

  • 11. Fluoxetine treatment of obsessive-compulsive disorder.
    Solyom L; Solyom C; Ledwidge B
    Can J Psychiatry; 1991 Dec; 36(10):723-7. PubMed ID: 1790516
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of treatment-refractory obsessive compulsive disorder patients.
    Dominguez RA; Mestre SM
    J Clin Psychiatry; 1994 Oct; 55 Suppl():86-92. PubMed ID: 7961537
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fluoxetine-clomipramine interaction.
    Sternbach H
    J Clin Psychiatry; 1995 Apr; 56(4):171-2. PubMed ID: 7713858
    [No Abstract]   [Full Text] [Related]  

  • 14. Interim analysis clarification.
    Liebowitz MR; Foa EB; Kozak MJ
    J Clin Psychiatry; 1995 Sep; 56(9):435. PubMed ID: 7665548
    [No Abstract]   [Full Text] [Related]  

  • 15. Drug versus behavioral treatment of obsessive-compulsive disorder.
    Marks I
    Biol Psychiatry; 1990 Dec; 28(12):1072-4. PubMed ID: 2289004
    [No Abstract]   [Full Text] [Related]  

  • 16. An integrated approach to treatment of obsessive compulsive disorder.
    Greist JH
    J Clin Psychiatry; 1992 Apr; 53 Suppl():38-41. PubMed ID: 1532963
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fluvoxamine in obsessive-compulsive nonresponders to clomipramine or fluoxetine.
    Mattes JA
    Am J Psychiatry; 1994 Oct; 151(10):1524. PubMed ID: 8092352
    [No Abstract]   [Full Text] [Related]  

  • 18. Clomipramine, self-exposure and therapist-aided exposure for obsessive-compulsive rituals.
    Marks IM; Lelliott P; Basoglu M; Noshirvani H; Monteiro W; Cohen D; Kasvikis Y
    Br J Psychiatry; 1988 Apr; 152():522-34. PubMed ID: 3167404
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Obsessive-compulsive disorder.
    March JS; Johnston H; Greist JH
    Am Fam Physician; 1989 May; 39(5):175-82. PubMed ID: 2497627
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomized, placebo-controlled trial of exposure and ritual prevention, clomipramine, and their combination in the treatment of obsessive-compulsive disorder.
    Foa EB; Liebowitz MR; Kozak MJ; Davies S; Campeas R; Franklin ME; Huppert JD; Kjernisted K; Rowan V; Schmidt AB; Simpson HB; Tu X
    Am J Psychiatry; 2005 Jan; 162(1):151-61. PubMed ID: 15625214
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.